InvestorsHub Logo
Followers 27
Posts 1829
Boards Moderated 0
Alias Born 08/25/2015

Re: ExtremelyBullishZig post# 293294

Monday, 01/18/2021 11:16:16 PM

Monday, January 18, 2021 11:16:16 PM

Post# of 470013
Actually, the company already disclosed they are jumping into (2) pivotal, phase2/3 trials for rare diseases. One of those is Fragile X and the other is undisclosed. Technically, they are setting themselves up for 2 more approvals if they can measure improvement in these indications.

The key here is they are cutting out years of development time from these rare diseases - BASED ON THE RESULTS FROM 1 TRIAL. This accomplishment certainly didnt get the recognition it deserved, imo.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News